A blood-based nutritional risk index explains cognitive enhancement and decline in the multidomain Alzheimer prevention trialShow others and affiliations
2019 (English)In: Alzheimer’s & Dementia: Translational Research & Clinical Interventions, E-ISSN 2352-8737, Vol. 5, no 1, p. 953-963Article in journal (Refereed) Published
Abstract [en]
Introduction: Multinutrient approaches may produce more robust effects on brain health through interactive qualities. We hypothesized that a blood-based nutritional risk index (NRI) including three biomarkers of diet quality can explain cognitive trajectories in the multidomain Alzheimer prevention trial (MAPT) over 3-years.
Methods: The NRI included erythrocyte n-3 polyunsaturated fatty acids (n-3 PUFA 22:6n-3 and 20:5n-3), serum 25-hydroxyvitamin D, and plasma homocysteine. The NRI scores reflect the number of nutritional risk factors (0–3). The primary outcome in MAPT was a cognitive composite Z score within each participant that was fit with linear mixed-effects models.
Results: Eighty percent had at lease one nutritional risk factor for cognitive decline (NRI ≥1: 573 of 712). Participants presenting without nutritional risk factors (NRI=0) exhibited cognitive enhancement (β = 0.03 standard units [SU]/y), whereas each NRI point increase corresponded to an incremental acceleration in rates of cognitive decline (NRI-1: β = −0.04 SU/y, P = .03; NRI-2: β = −0.08 SU/y, P < .0001; and NRI-3: β = −0.11 SU/y, P = .0008).
Discussion: Identifying and addressing these well-established nutritional risk factors may reduce age-related cognitive decline in older adults; an observation that warrants further study.
Place, publisher, year, edition, pages
2019. Vol. 5, no 1, p. 953-963
Keywords [en]
Nutrient biomarkers, Metabolomics, Biomarkers of diet quality, Omega-3 fatty acids, DHA, EPA, Homocysteine, Vitamin D, Aging, Elderly, Cognitive decline
National Category
Nutrition and Dietetics Neurosciences Gerontology, specialising in Medical and Health Sciences
Identifiers
URN: urn:nbn:se:su:diva-260867DOI: 10.1016/j.trci.2019.11.004ISI: 000737692800099Scopus ID: 2-s2.0-85077017706OAI: oai:DiVA.org:su-260867DiVA, id: diva2:2110515
Note
For correction, see: Alzheimer’s Dement. 2020;6:e12042. DOI: 10.1016/j.trci.2019.11.004
2026-10-152026-10-152026-10-15Bibliographically approved